Claudia Mattern
Emmetten, NW, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Intranasal dopamine: anatomical pathways, biological mechanisms and neuromodulatory potential.
Journal: Neuroscience and biobehavioral reviews
Published: March 18, 2026
The Smoothened agonist SAG Modulates the Male and Female Peripheral Immune Systems Differently in an Immune Model of Central Nervous System Demyelination.
Journal: Cells
Published: February 21, 2024
Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders.
Journal: Pharmaceutics
Published: November 08, 2023
Testosterone Inhibits Secretion of the Pro-Inflammatory Chemokine CXCL1 from Astrocytes.
Journal: Current issues in molecular biology
Published: July 21, 2023
D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance.
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 14, 2022
Dissolution Improvement of Progesterone and Testosterone via Impregnation on Mesoporous Silica Using Supercritical Carbon Dioxide.
Journal: AAPS PharmSciTech
Published: August 11, 2022
Sex differences in the cerebroprotection by Nestorone intranasal delivery following stroke in mice.
Journal: Neuropharmacology
Published: April 20, 2021
The activation of D2-like receptors by intranasal dopamine facilitates the extinction of contextual fear and prevents conditioned fear-induced antinociception.
Journal: Behavioural brain research
Published: March 02, 2021
Acute intranasal dopamine application counteracts the reversal learning deficit of spontaneously hypertensive rats in an attentional set-shifting task.
Journal: Psychopharmacology
Published: October 13, 2020
Last Updated: 09/26/2026